N. Mohammed
- Oncology top 5%
- Lung Cancer Research Studies 6
- Cancer Research top 10%
- MicroRNA in disease regulation 2
-
- Lung Cancer Diagnosis and Treatment 12
- Lung Cancer Treatments and Mutations 9
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 2
- Radiation top 10%
- Advanced Radiotherapy Techniques 4
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
N. Mohammed
25 papers receiving 968 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 547
- Cancer Research 212
- Pulmonary and Respiratory Medicine 354
- Epidemiology 274
- Radiation 56
Countries citing papers authored by N. Mohammed
This map shows the geographic impact of N. Mohammed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Mohammed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Mohammed more than expected).
Fields of papers citing papers by N. Mohammed
This network shows the impact of papers produced by N. Mohammed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Mohammed. The network helps show where N. Mohammed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. Mohammed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | Thoracic radiotherapy decreases right ventricle function : first results of the CLARIFY study | 2020 | 1 |
| 4 | 2020 | 0 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 20 | |
| 7 | 2019 | 0 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 1 | |
| 10 | Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialbreakdown → | 2017 | 354 |
| 11 | 2017 | 1 | |
| 12 | 2016 | 22 | |
| 13 | 2013 | 57 | |
| 14 | 2012 | 8 | |
| 15 | 2012 | 11 | |
| 16 | 2011 | 249 | |
| 17 | 2011 | 23 | |
| 18 | 2008 | 154 | |
| 19 | 2007 | 31 | |
| 20 | 2000 | 1 |
About N. Mohammed
N. Mohammed is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology, having authored 28 papers that have together received 977 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers), Advanced Radiotherapy Techniques (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Oncology (547 citations), Cancer Research (212 citations) and Pulmonary and Respiratory Medicine (354 citations). N. Mohammed has collaborated with scholars based in United Kingdom, Spain and Belgium. Frequent co-authors include Susan Harden, Michael R. MacDonald, Ewan MacDermid, Derek Grose, C. Porteous, Corinne Faivre‐Finn, M. Snee, Mary O’Brien, R. McMenemin and Fabrice Barlési. Their work appears in journals such as Lung Cancer, Radiotherapy and Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and Veterinary Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.